ArticleJournal of the National Cancer Institute2022

Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint Therapy.

Sungyong You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.